Engineered AAV9 as <i>in vivo</i> gene delivery platform for the selective transduction of TME cell subsets
Muhammed Burak Demircan(Paul Ehrlich Institut), Christian J. Buchholz(Paul Ehrlich Institut)
Cited by 0
Related Papers
In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
|EMBO Molecular Medicine|2018|188
Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment
|PLoS Pathogens|2016|98
AAV vectors displaying bispecific DARPins enable dual-control targeted gene delivery
|Biomaterials|2023|27
T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8
|Molecular Therapy|2024|25
Genetic in vivo engineering of human T lymphocytes in mouse models
|Research Square|2020|1